T2Biosystems Demonstrates First-Ever Ability to Accurately and Rapidly Detect Systemic Candida Infection Directly in Whole Blood in Single-Process Test

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.